Behavioral profiles displayed by rats in an elevated asymmetric plus-maze: Effects of diazepam

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 1, 1999, Pages 99-106

  Ruarte, M B ^a   Alvarez, E O ^a,b,c  

^a UNIVERSIDAD NACIONAL DE CUYO   (Argentina)

^b Universidad Nacional de Cuyo Facultad de Ciencias Medicas   (Argentina)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

"Anxiety"; Benzodiazepine; Conflictive exploration; Elevated asymmetric plus maze; Emotionality; Motivation

Indexed keywords

ANIMALIA;

BENZODIAZEPINE DERIVATIVE; DIAZEPAM;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; EXPLORATORY BEHAVIOR; FEAR; GEOMETRY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; NONHUMAN; RAT; SCORING SYSTEM; SEDATION;

EID: 0032899220     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000100015     Document Type: Article

References (21)

1. Pellow S, Chopin P, File SE & Briley M (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14: 149-167.
2. Pellow S & File SE (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus maze: a novel test of anxiety in the rat. Pharmacology, Biochemistry and Behavior, 24: 525-529.
3. 2 receptor ligands modulated the behavior of mice in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 49: 985-995.
4. Cruz APM, Frei F & Graeff FG (1994). Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 49: 171-176.
5. Shepherd JK, Grewal S, Fletcher A, Bill DJ & Dourish CT (1994). Behavioural and pharmacological characterization of the elevated "zero maze" as an animal model of anxiety. Psychopharmacology, 116: 56-64.
6. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B & Junien JL (1995). Behavioral effects of neuropeptide Y receptor agon sts in the elevated plus-maze and fear-potentiated startle procedures. Behavioural Pharmacology, 6: 215-222.
7. Dawson GR & Tricklebank MD (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends in Pharmacological Sciences, 16: 33-36.
8. Rex A, Sondern U, Voigt JP, Franck S & Fink H (1996). Strain differences in fear-motivated behavior of rats. Pharmacology, Biochemistry and Behavior, 54: 107-111.
9. Hogg S (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behavior, 54: 21-30.
10. Korte SM, de Boer SF, de Kloet ER & Bohus B (1995). Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze. Psychoneuroendocrinology, 20: 385-394.
11. Rodgers RJ, Cole JC, Aboualfa K & Stephenson LH (1995). Ethopharmacological analysis of the effects of putative "anxiogenic" agents in the mouse elevated plus-maze. Pharmacology, Biochemistry and Behavior, 52: 805-813.
12. Viana MB, Tomaz C & Graeff FG (1994). The elevated T-maze: a new animal model of anxiety and memory. Pharmacology, Biochemistry and Behavior, 49: 549-554.
13. Ruarte MB, Orofino AG & Alvarez EO (1997). Hippocampal histamine receptors and conflictive exploration in the rat: studies using the elevated asymmetric plus-maze. Brazilian Journal of Medical and Biological Research, 30: 1451-1461.
14. Dunn OJ (1964). Multiple comparisons using rank sums. Technometrics, 6: 241-252.
15. Chaouloff F, Durand M & Mormede P (1997). Anxiety- and activity-related effects of diazepam and chlordiazepoxide in the rat light/dark and dark/light tests. Behavioural Brain Research, 85: 27-35.
16. Dawson GR, Crawford SP, Collinson N, Iversen SD & Tricklebank MD (1995). Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus-maze are confounded by increases in locomotor activity. Psychopharmacology, 118: 316-323.
17. Olivier B, Molewijk E, Oorschot van R, Poel van der G, Zethof T, Heyden van der J & Mos J (1994). New animal models of anxiety. European Neuropsychopharmacology, 4: 93-102.
18. Mogeson GJ, Jones DL & Yim CY (1980). From motivation to action: functional interface between the limbic system and the motor system. Progress in Neurobiology, 14: 69-97.
19. Salamone JD (1992). Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes. Psychopharmacology, 107: 160-174.
20. Salamone JD (1991). Behavioral pharmacology of dopamine systems: a new synthesis. In: Willner P & Scheel-Kruger J (Editors), The Mesolimbic Dopamine System: From Motivation to Action. Cambridge University Press, England, 599-613.
21. Widgiz LM & Beck CHM (1990). Diazepam effects on the exploratory behavior of rats in an elevated runway: evidence for biphasic effects of benzodiazepines. Behavioural Brain Research, 40: 109-118.